Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Time in range was similar among pediatric patients with type 1 diabetes who used either the Insulet Omnipod 5 or the Tandem Control IQ.

In a new study, researchers found that time-in-range for healthy blood sugar could be a viable marker of glycemic control and potentially could be used to predict complications of type 1 diabetes.

Flexis, the joint venture for highly connected electric vans founded in 2024 by Renault, the Volvo Group and logistics ...

In the case of the OOCL Brisbane, all the ship’s mooring lines parted or paid out, and it moved into the Brisbane River ...

Families want nurse or staff to monitor apps remotely in case of urgent alarms; schools cite shrinking budgets and internet ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced new findings ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, my name is Gigi [ph], and I’ll be your conference operator ...